| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |